Leo has 18 years of experience leading development and commercialization of advanced machine learning, AI, computer vision, diagnostic and digital health technologies that have made a significant impact on healthcare practice. During his tenure as CEO of Paige, Leo led the company to become an industry leader, internationally launched several groundbreaking software products and became the first-ever company to receive FDA approval for an AI product in pathology. Leo is currently CEO in Residence with Breyer Capital.
Prior to joining Paige, Leo was the SVP of Engineering for HeartFlow, where he led full stack technology and product development efforts for HeartFlow’s cardiovascular diagnostic and treatment planning software while also driving HeartFlow’s IP portfolio. Before HeartFlow, Leo served in various technology and leadership roles at Siemens healthcare. Leo is internationally recognized as a technology leader in AI for healthcare, authoring two books, over 100 peer-reviewed scientific papers and having over 300 patents worldwide. Winner of the 2012 Edison Patent Award, he was inducted as a Fellow in the American Institute for Medical and Biological Engineering. Leo received the B.Sc. degree in Electrical Engineering at the University of Vermont and a Ph.D. in Cognitive and Neural Systems from Boston University.